Division of Cardiovascular Medicine Archives
Peptides promote AFib arrhythmia
Apr. 11, 2022—Peptide oligomers have detrimental metabolic effects and cause pro-arrhythmic electrophysiological changes in heart atria, suggesting they may contribute to atrial fibrillation.
Department of Medicine announces $1 million endowment to support diversity, inclusion efforts
Mar. 14, 2022—Vanderbilt University Medical Center’s Department of Medicine has announced a $1 million endowment dedicated to the department’s efforts in diversity and inclusion.
American College of Cardiology honors Vanderbilt’s Dixon, Thomas
Mar. 10, 2022—Two fellows in Vanderbilt's Division of Cardiovascular Medicine have received awards from the American College of Cardiology and the Association of Black Cardiologists.
Chest Pain Center receives reaccreditation from ACC
Mar. 3, 2022—Vanderbilt University Medical Center has been reaccredited as a Chest Pain Center with Primary Percutaneous Coronary Intervention (PCI) and Resuscitation.
Study finds genetic testing useful for young AFib patients
Oct. 7, 2021—Vanderbilt research shows that genetic testing in patients with early-onset atrial fibrillation can identify variants associated with more serious cardiomyopathy and arrhythmia syndromes that may otherwise remain undiagnosed.
Stevenson receives HFSA Lifetime Achievement Award
Sep. 23, 2021—Vanderbilt's Lynne Warner Stevenson, MD, has received the Lifetime Achievement Award from the Heart Failure Society of America.
New Clinician Spotlight: Jane Freedman
Sep. 8, 2021—Jane Freedman, MD, has joined Vanderbilt University Medical Center as director of the Division of Cardiovascular Medicine and physician-in-chief of the Vanderbilt Heart and Vascular Institute.
Regulators of fat cell metabolism
Sep. 7, 2021—Vanderbilt researchers have discovered new details of the regulation of fat cell metabolism, findings that are important for combating obesity.
Potential protection from atherosclerosis
Aug. 19, 2021—Vanderbilt researchers have discovered a potential way to reduce atherosclerosis: blocking the modification of an HDL-associated enzyme by reactive molecules called isolevuglandins.
COVID-19 complication underdiagnosed
Jun. 17, 2021—A mysterious inflammatory syndrome linked to COVID-19 infection and first identified in children also occurs in adults, Vanderbilt researchers report.
New Clinician Spotlight: Andrew DeFilippis
Jun. 1, 2021—Andrew DeFilippis, MD, has joined Vanderbilt University Medical Center from the University of Louisville School of Medicine. He began seeing patients in September 2020.
Residents, fellows step up to help care for COVID patients
Jan. 14, 2021—Following a Thanksgiving surge that led to record numbers of admissions of patients with COVID-19, residents and fellows from multiple disciplines have come together under the direction and supervision of critical care attendings to provide the best care to critically ill patients in Vanderbilt University Medical Center’s COVID-19 Intensive Care Unit.
